Journal article icon

Journal article

Fracture risk following intermission of osteoporosis therapy

Abstract:

Summary

Given the widespread practice of recommending drug holidays, we reviewed the impact of medication discontinuation of two common anti-osteoporosis therapies (bisphosphonates and denosumab). Trial evidence suggests the risk of new clinical fractures, and vertebral fracture increases when osteoporosis treatment with bisphosphonates or denosumab is stopped.

Introduction

The aim of this paper was to review the available literature ...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1007/s00198-019-05002-w

Authors


Publisher:
Springer
Journal:
Osteoporosis International More from this journal
Volume:
30
Issue:
9
Pages:
1733–1743
Publication date:
2019-06-07
Acceptance date:
2019-03-26
DOI:
EISSN:
1433-2965
ISSN:
0937-941X
Language:
English
Keywords:
Pubs id:
pubs:986782
UUID:
uuid:cd690930-08f5-4c3b-8411-419b638331d9
Local pid:
pubs:986782
Source identifiers:
986782
Deposit date:
2019-03-29

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP